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Potential Molecular Mechanisms of
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Chronic exposure to oxidants is associated with an increased incidence of malignancy; however, the mechanism(s) by which oxidants contribute to
carcinogenesis is unknown. Since oncogene activation plays an important role in carcinogenesis, we hypothesized that hydroxyl radical-induced
DNA damage might contribute to carcinogenesis by causing oncogene activation. The studies reported herein demonstrate that hydroxyl radical-
induced DNA damage can activate the K-ras 4B and C-Raf-I oncogenes by causing point mutations and deletions, respectively. In addition, our
results indicate that a) hydroxyl radical-induced DNA damage causes selective base substitutions; b) the four DNA bases have different susceptibili-
ties to hydroxyl radical-induced mutations; and c) hydroxyl radical-induced mutations are not randomly distributed among oncogene codons. Our
studies suggest that oncogene activation could be one potential mechanism by which oxidants contribute to carcinogenesis. - Environ Health
Perspect 102(Suppl 10):155-158 (1994)
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Introduction
Chronic exposure to oxidants, such as
those generated by inflammatory leuko-
cytes or cigarette smoke, is associated with
an increased incidence of malignancy (1).
However, the mechanism(s) by which oxi-
dants might contribute to carcinogenesis is
unknown. In this report I will briefly sum-
marize some ofthe recent studies from our
laboratory aimed at determining potential
molecular mechanisms by which oxidants
might contribute to carcinogenesis.
Currently, there are believed to be two
major mechanisms by which normal cells
can be converted into malignant cells.
These include the conversion of normal
protooncogenes into activated oncogenes,
and the inactivation of normal tumor sup-
pressor genes. In general, protein products
of protooncogenes transduce growth stimu-
lating signals, while the protein products of
tumor suppressor genes transduce growth
inhibiting signals. In normal cells, the activ-
ity of protooncogene and tumor suppressor
gene protein products can be reversibly
switched on or off by precisely controlled
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cellular mechanisms. Accordingly, the
growth and differentiation of normal cells
can be carefully regulated by modulating
the relative activity of these protein prod-
ucts. However, when the protooncogenes
or tumor suppressor genes of normal cells
undergo genetic alterations (such as point
mutations, deletions, rearrangements, allelic
loss, etc.), the normal regulation of cell
growth and differentiation can become dis-
rupted. For instance, if genetic damage
converts normal protooncogenes into acti-
vated oncogenes, the protein products of
these activated oncogenes can transduce a
continuous growth stimulating signal that
cannot be turned off. Likewise, damage to
tumor suppressor genes can render their
protein products inactive and incapable of
inhibiting cell growth. Therefore, the accu-
mulation ofactivated oncogenes and inacti-
vated tumor suppressor genes in a given cell
could lead to disregulated cell growth, and
this disregulated cell growth could ulti-
mately contribute to carcinogenesis.
Given the important role of oncogene
activation and tumor suppressor gene inac-
tivation in carcinogenesis, we hypothesized
that oxidants might contribute to carcino-
genesis by causing oncogene activation or
tumor suppressor gene inactivation.
Previous studies from our laboratory, as
well as others, have shown that leukocytes
or cigarette smoke release superoxide and
hydrogen peroxide that can, in the presence
of catalytic amounts of iron, be converted
into the very potent oxidant, hydroxyl radi-
cal (-OH); and this -OH appears to be the
specific oxidant responsible for inducing
DNA base damage and DNA strand breaks
(2-20). We hypothesized, therefore, that
-OH-induced DNA base damage and DNA
strand breaks might cause point mutations
and deletions, respectively, that could lead





Let us first consider the ability of -OH-
induced DNA base damage to cause
oncogene activation. Utilizing gas chroma-
tography-mass spectroscopy with selected
ion monitoring (GC-MS/SIM), we showed
that approximately 7 out of every 1,000
DNA bases became modified when isolated
DNAwas exposed to physiologic concentra-
tions of PMA-stimulated neutrophils and
Fe+ (7). The specific base modifications
detected included (in order of decreasing
yield) 8-hydroxyguanine, 8-hydroxyadenine
(more correctly referred to as 7,8-dihydro-8-
oxyguanine and 7,8-dihydro-8-oxoadenine),
cytosine glycol, 2,6-diamino-4-hydroxy-5-
formamidopyrimidine, thymine glycol, and
4,6-diamino-5-formamidopyrimidine. In
order to determine ifthese different types of
DNA base modifications could cause DNA
base mispairing, that could result in point
mutations and lead to oncogene activation,
we used the K-ras protooncogene as our
model protooncogene, because this pro-
tooncogene is known to be activated into a
transforming oncogene by point mutations
(21). K-ras is also a very relevant model for
studies of human carcinogenesis, because it
is the most frequent oncogene activated in
human malignancies (it is activated in 30 to
40% oflung adenocarcinomas; 40 to 50%
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ofcolon carcinomas; and 90 to 95% ofpan-
creatic carcinomas).
The K-ras protooncogene encodes a 21
kD GTP-binding protein. The function of
the normal K-rasprotooncogene is unknown,
but it is believed to play a crucial role in
cell growth and differentiation. The nor-
mal K-ras protooncogene can be converted
into a transforming activated oncogene in
vivo by point mutations at codons 12, 13,
and 61, and in vitro by mutations at
codons 12, 13, 59, 61, 63, 116 to 119, or
146 (21). The activity of K-ras proteins
containing these mutations cannot be
turned off, and therefore these mutant pro-
teins continuously transduce growth stimu-
latory signals. To determine if 'OH could
convert the normal K-ras protooncogene
into an activated oncogene, we exposed the
normal K-ras protooncogene cDNA (con-
tained in a pZIP mammalian expression
vector) to a variety ofdifferent 'OH-gener-
ating systems. Specifically these 'OH-gen-
erating systems included: PMA (250
ng/ml) + neutrophils (4x 106/ml); solubi-
lized cigarette smoke (1/3000 of 1 cigarette
in PBS); or purine (2 mM) + xanthine oxi-
dase (0.002 u/ml); in the presence or
absence of Fe2+/EDTA (10 pM/20 pM).
'OH-exposed K-ras protooncogene DNA
was subsequently transfected into mouse
fibroblast NIH 3T3 cells and cells were
analyzed after 14 days for evidence ofmor-
phologically transformed foci. DNA from
these transformed foci was extracted,
amplified by the polymerase chain reaction,
and sequenced. We found that approxi-
mately 25 to 30% ofthe dishes transfected
with K-ras DNA that had been treated
with PMA-stimulated leukocytes, cigarette
smoke, or purine and xanthine oxidase, in
the presence of Fe2+, developed trans-
formed foci. In contrast, no transformed
foci developed in the absence ofFe2+ or in
the presence ofFe2+ alone. Sequence analy-
sis of our K-ras transformants revealed
mutations predominantly at codons 12 and
61 although a few mutations occurred at
other sites including codons 13, 18, 117,
and 146. In addition, sequence analysis of
our K-ras transformants suggested that
there may be several characteristics of'OH-
induced K-ras oncogene activation. First,
'OH-induced DNA damage appeared to
cause selective base substitutions.
Specifically, guanine bases were exclusively
converted to adeninines or thymines; ade-
nine was exclusively converted to thymine;
and cytosine was exclusively converted to
adenine. Second, the four DNA bases
appeared to have different susceptibilities
to -OH-induced mutations. Specifically,
guanine and adenine bases appeared to be
much more susceptible to 'OH-induced
attack than cytosine and thymine bases.
Third, the preponderance of mutations at
codons 12 and 61 indicated that *OH-
induced mutations are not randomly dis-
tributed among the K-ras codons; and
fourth, the pattern of mutations observed
in our studies correlated well with the pat-
tern of mutations detected in human and
rodent carcinomas.
Although the aforementioned studies
clearly indicate that 'OH can cause point
mutations and activate the K-rasprotoonco-
gene, it was impossible to definitively con-
clude from these studies that point
mutations were specifically due to DNA
base modifications (rather than DNA strand
breaks, etc.). Accordingly, to more firmly
establish that DNA base modifications can
cause point mutations and K-ras oncogene
activation, we incorporated chemically syn-
thesized 8-hydroxydeoxyguanosine [the
most prevalent 'OH-modified DNA base
in our studies (7)] into the first or second
position of codon 12 of the normal K-ras
protooncogene; transfected this 8-hydroxy-
deoxyguanosine-containing K-ras pro-
tooncogene DNA into NIH 3T3 cells; and
analyzed these cells for the development of
transformed foci. DNA from transformed
foci was subsequently extracted, amplified
by the polymerase chain reaction, and
sequenced. We found that incorporation of
8-hydroxydeoxy-guanosine into the first or
second positions ofcodon 12 caused G to A
transitions and G to T transversions at
codon 12. Moreover, the pattern ofthese G
-< A and G -< T transitions and transver-
sions was identical to the pattern observed
in our aforementioned studies of 'OH-
treated K-ras DNA. Similar results, utilizing
the H-ras protooncogene, have been
obtained by Kamiya et al. (22). These stud-
ies indicate, therefore, that 'OH-modified
DNA bases can cause point mutations that




In light of the ability of 'OH-modified
DNA bases to activate oncogenes, we were
also interested in determining if-OH-
induced DNA strand breaks might also
cause oncogene activation. Specifically, we
hypothesized that DNA strand breaks
might cause deletions that could lead to
oncogene activation. To test our hypothe-
sis, we used the C-Raf-1 protooncogene,
because this protooncogene is known to be
activated into a transforming oncogene by
deletion ofits N-terminus (23). C-Raf-1 is
believed to be an important downstream
component of the Ras signal transduction
pathway, and activated C-Raf-1 oncogenes
are frequently detected in human malig-
nancies.
The C-Raf-1 protooncogene encodes a
74 kD protein. The N-terminus ofC-Raf-1
contains a regulatory domain; while its C-
terminus contains a Ser/Thr kinase
domain. The Ser/Thr kinase activity of C-
Raf-1 proteins that have lost their N-termi-
nal regulatory domain, cannot be turned
off; therefore these proteins continuously
transduce growth stimulatory signals. In
order to determine if-OH could cause N-
terminal deletions and convert the normal
C-Raf-1 protooncogene into an activated
oncogene, we exposed the normal C-Raf-1
protooncogene cDNA (contained in a
mammalian expression vector) to the same
'OH-generating systems that we used in
the aforementioned isolated K-ras pro-
tooncogene cDNA studies. 'OH-treated C-
Raf-1 protooncogene cDNA was
transfected into NIH 3T3 cells and DNA
from transformed foci was extracted and
PCR amplified, as outlined above. We
found that approximately 20 to 25% of
dishes transfected with 'OH-treated C-Raf
1 DNA developed transformed foci. No
transformed foci occurred in the absence of
Fe2+ or in the presence of Fe2+ alone. We
have not completed our analysis of the C-
Raf1 transformants, however preliminary
analysis by Southern blots suggest that C-
Raf-1 oncogene activation occurred as a
result ofN-terminal deletions. These stud-
ies suggest, therefore, that 'OH-induced
DNA strand breaks can cause deletions and
result in oncogene activation.
The aforementioned studies indicate
that 'OH-induced DNA base damage and
'OH-induced DNA strand breaks can
cause oncogene activation and it is likely
that this oncogene activation could ulti-
mately contribute to carcinogenesis. It will
be important to determine if-OH-induced
DNA base damage and DNA strand breaks





There exists anotherpotential mechanism by
which oxidants might contribute to carcino-
genesis. Previous studies (24,25) have shown
that cells containing the normal tumor sup-
pressor genep53 undergo DNAdamage and
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G1 cell cycle arrest when they are treated
with gamma irradiation. This GI cell cycle
arrest allows the cells to repair their damaged
DNA, and only after the damaged DNA is
repaired do the cells resume their cell cycle.
Therefore, this G1 cell cycle arrest prevents
cells containing damaged DNA from repli-
cating their damaged DNA. Interestingly,
cells that contain a mutant or absent p53
tumor suppressor gene fail to undergo GI
cell cycle arrest when exposed to gamma irra-
diation (24,25). These cells continue to
undergo gamma irradiation-induced DNA
damage, the lack of G1 cell cycle arrest
enables these cells to replicate damaged
DNA. In preliminary studies from our lab-
oratory, we have found that leukocyte-
derived OH also causes GI cell cycle arrest
in cells with normal p53, but fails to cause
G1 cell cycle arrest in cells with mutant or
absent p53. Since the lack of Gl cell cycle
arrest enables cells that contain mutant p53
to replicate damaged DNA, the fidelity of
replication is likely to be significantly
reduced. Errors in replication can result in
oncogene activation as well as inactivation of
additional tumor suppressor genes. There-
fore, in addition to the possibility that OH-
induced DNA damage might directly
inactivate tumor suppressor genes, it is possi-
ble that cells containing inactivated tumor
suppressor genes (whether inactivated by
OH or some other factor) are essentially "set
up" to undergo oncogene activation and
additional tumor suppressor gene inactiva-
tion when exposed to OH, because oftheir
inability to undergo GI cell cycle arrest fol-
lowing DNAdamage.
Conclusion
In summary, our studies support the fol-
lowing model of oxidant-induced carcino-
genesis: leukocytes or cigarette smoke
release superoxide and hydrogen peroxide;
hydrogen peroxide diffuses into the
nucleus ofcells and reacts with iron that is
either bound to or close to DNA and gen-
erates -OH; OH causes DNA base damage
and DNA strand breaks that lead to onco-
gene activation or tumor suppressor gene
inactivation; tumor suppressor gene inacti-
vation (caused by OH or some other fac-
tor) further predisposes cells to develop
oncogene activation and tumor suppressor
gene inactivation, following OH exposure;
the accumulation of activated oncogenes
and inactivated tumor suppressor genes
ultimately results in carcinogenesis.
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